Bison Ventures β 2025 Investments
4 investments dated 2025 Β· listed companies and verified rows first Β· show all
Great Sky develops physics-based computational intelligence and AI systems built from foundational research.
AI & Machine LearningDeep TechHardwareBoulder, US
Jeffrey Shainline(Executive Officer, Director)inMark Wade(Director)in
Board seatTom BiegalaΒ· per SEC Form D
Co-investorsMatchstick VenturesMythos Ventures Management, LlcRange VCService Provider CapitalWireframe Ventures
Juvena Therapeutics develops biologics derived from human secreted proteins to treat aging-related diseases, using AI-enabled drug discovery to identify tissue-restorative therapeutics for muscle and metabolic disorders.
AI & Machine LearningBiotechLongevityMedical DevicesRedwood City, US
Jeremy O'Connell, PhD(Chief Scientific Officer and Co-Founder)Hanadie Yousef, PhD(Executive Advisor and Co-Founder)Hanadie Yousef(Executive Officer, Director)Jeremy O'Connell(Director)Dr. Hanadie Yousef(Founder)in
Board seatBen HemaniΒ· per SEC Form D
Co-investorsBascom VenturesCompoundHarmonix FundHorizons VenturesManta Ray VenturesOpen Field Capital+3 more
Sleuth provides evidence-backed answers for biopharma decision-making, built on a knowledge graph that maps over a billion relationships across biology, clinical evidence, competitive dynamics, and deal history.
AI & Machine LearningBiotechData & InfrastructureFintechSan Francisco, US
Andrew Pannu(Executive Officer, Director)
BoardMark Jacobstein(Director)
Board seatCaleb AppletonΒ· per SEC Form D
Co-investorsHAWKTAILAtria Ventures
Bonsai Robotics develops autonomy technology and equipment, including its Amiga lineup powered by Bonsai Intelligence, to automate off-road jobs for operations ranging from small businesses to large companies.
AgTechAI & Machine LearningRobotics
Co-investorsAcre Venture PartnersBetter Food VenturesCongruent VenturesSerra VenturesSoundproof VenturesThe E14 Fund+2 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.